Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125396111 | 12539611 | 1 | I | 20160601 | 20160708 | 20160708 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119825 | RANBAXY | GOTO A, ITOH M, WAKASUGI H, KANNO S, YABANA T, MITSUHASHI K, ET AL. A CASE OF RECURRENT GASTRIC CANCER SHOWING PARTIAL RESPONSE TO CAPECITABINE/CDDP AFTER TREATMENT WITH S-1/ CDDP. GAN-TO-KAGAKU-RYOHO. 2012;39(10):1563-1566 | 71.00 | YR | M | Y | 55.00000 | KG | 20160708 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125396111 | 12539611 | 1 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | 3000 MG, DAILY, ON DAY 1-14 | U | 0 | 3000 | MG | |||||||
| 125396111 | 12539611 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 60 MG/M2, Q3WKS, ON DAY 1 | U | U | 0 | 60 | MG/M**2 | ||||||
| 125396111 | 12539611 | 3 | C | CAPECITABINE. | CAPECITABINE | 1 | Unknown | 2400 MG, DAILY | U | U | 0 | 2400 | MG | ||||||
| 125396111 | 12539611 | 4 | PS | Irinotecan | IRINOTECAN | 1 | Unknown | 150 MG/M2, FORTNIGHT | U | U | 78805 | 150 | MG/M**2 | ||||||
| 125396111 | 12539611 | 5 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | 80 MG/M2, ON DAY 1,8, 15, Q4WKS | U | U | 0 | 80 | MG/M**2 | ||||||
| 125396111 | 12539611 | 6 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | 60 MG/M2, Q3WKS | U | U | 0 | 60 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125396111 | 12539611 | 1 | Gastric cancer stage III |
| 125396111 | 12539611 | 2 | Gastric cancer stage III |
| 125396111 | 12539611 | 3 | Gastric cancer stage III |
| 125396111 | 12539611 | 4 | Gastric cancer stage III |
| 125396111 | 12539611 | 5 | Gastric cancer stage III |
| 125396111 | 12539611 | 6 | Gastric cancer stage III |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125396111 | 12539611 | HO |
| 125396111 | 12539611 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125396111 | 12539611 | Decreased appetite | |
| 125396111 | 12539611 | Disease progression | |
| 125396111 | 12539611 | Drug effect incomplete | |
| 125396111 | 12539611 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125396111 | 12539611 | 1 | 20110614 | 0 | ||
| 125396111 | 12539611 | 2 | 20110614 | 0 | ||
| 125396111 | 12539611 | 4 | 20090907 | 0 | ||
| 125396111 | 12539611 | 5 | 20091212 | 0 | ||
| 125396111 | 12539611 | 6 | 20100311 | 0 |